On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...

The FDA announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to ...

Leading scientists and bioethicists are urging the creation of an international oversight body to monitor advances in human ...

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by Novo Nordisk and Eli Lilly — offering more coverage for Medicare and Medicaid ...

The Food and Drug Administration is considering whether and how to regulate therapy chatbots that are based on large language models. Today, the agency’s Digital Health Advisory Committee is meeting ...

If Congress does extend the enhanced subsidies into next year, policymakers and insurance companies can do a few things to ...

Pfizer is preparing to sweeten its offer again for Metsera, the weight loss drug startup at the center of a bidding war with ...

Morning! Join us later today for a virtual event with STAT’s Jason Mast and Damian Garde about the past and future of Moderna ...

On Tuesday, President Trump threatened to defy court orders and withhold emergency funding for SNAP, or food stamps, until the end of the government shutdown. The White House press secretary quickly ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

The complete response letter has not yet been posted to the FDA website, but according to Biohaven, the agency rejected its ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...